These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8438073)

  • 1. The epidemiology and control of hepatitis B in sub-Saharan Africa.
    Kiire CF
    Prog Med Virol; 1993; 40():141-56. PubMed ID: 8438073
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa.
    Kiire CF
    Prog Liver Dis; 1993; 11():167-78. PubMed ID: 8272509
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
    Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ
    Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B--another vaccine success story.
    Child Health Alert; 2005 Jan; 23():3. PubMed ID: 15799101
    [No Abstract]   [Full Text] [Related]  

  • 5. Continue to vaccinate against hepatitis B.
    Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the epidemiological situation of hepatitis B in Kielce region, after introduction of vaccination of infants against hepatitis B].
    Patrzałek M; Tarnowska H
    Przegl Epidemiol; 1999; 53(1-2):181-5. PubMed ID: 10402866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The task of epidemiology in designing strategies for the use of hepatitis B virus vaccine.
    Kane MA
    Public Health Rep; 1984; 99(3):264-6. PubMed ID: 6234611
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of hepatitis B in China: achievements and challenges.
    Lu FM; Zhuang H
    Chin Med J (Engl); 2009 Dec; 122(24):2925-7. PubMed ID: 20137475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of Hepatitis B: a seriously French incoherence].
    Nau JY
    Rev Med Suisse; 2008 Jul; 4(165):1682. PubMed ID: 18767296
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis A and B vaccines].
    Hernández N; Chirino R; Fassio E; Cheinquer H
    Rev Gastroenterol Mex; 2006 Nov; 71 Suppl 2():73-89. PubMed ID: 17465191
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coverage of vaccination against hepatitis B in Poland in 2004].
    Magdzik W; Czarkowski MP
    Przegl Epidemiol; 2006; 60(2):185-92. PubMed ID: 16964668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desirability and feasibility of hepatitis B vaccine in EPI.
    Mittal SK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccines against viral hepatitis B: results and prospects].
    Mukomolov SL
    Tr Inst Im Pastera; 1992; 67():103-15. PubMed ID: 8539762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001].
    Magdzik W
    Przegl Epidemiol; 2006; 60(2):179-84. PubMed ID: 16964667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcomes of Polish hepatitis B vaccination program in comparison with European Union].
    Magdzik W
    Przegl Epidemiol; 2003; 57 Suppl 1():51-62. PubMed ID: 12921001
    [No Abstract]   [Full Text] [Related]  

  • 18. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination against hepatitis B].
    Madaliński K; Mikołajewicz J; Michalska Z
    Przegl Epidemiol; 1996; 50(1-2):3-14. PubMed ID: 8711156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.